Variables |
Controlled group (n=93) (51%) |
Uncontrolled group (n=89) (49%) |
p-values |
Female (%), М (95% CI) |
53.8 (43.4 – 64.1) |
69.7 (59.9 – 79.4) |
0.028 |
Age (yrs), Ме (LQ, UQ) |
66 (57, 74) |
68 (62, 75) |
0.059 |
BMI (kg/m2), Ме (LQ, UQ) |
29.2 (25.8, 32.2) |
29.4 (28.7, 37.7) |
0.921 |
Angina pectories (%), М (95% CI) |
16.1 (8.5 – 23.7) |
11.2 (4.5 – 17.9) |
0.339 |
Prior myocardial infarction (%), М (95% CI) |
22.6 (13.9 – 31.2) |
10.1 (3.7 – 16.5) |
0.024 |
CAD, other (%), М (95% CI) |
55.9 (45.6 – 66.2) |
73.0 (63.6 – 82.4) |
0.016 |
Peripheral arteries disease (%), М (95% CI) |
7.5 (2.1 – 12.9) |
7.9 (2.2 – 13.6) |
0.932 |
SBP (mm Hg), Ме (LQ, UQ) |
120 (115, 130) |
145 (140, 152) |
<0.001 |
DBP (mm Hg), Ме (LQ, UQ) |
70 (65, 80) |
85 (80, 90) |
<0.001 |
Total cholesterol (mg/dl), Ме (LQ, UQ) |
186 (171, 217) |
213 (190, 229) |
0.012 |
Triglycerides (mg/dl), Ме(LQ, UQ) |
72 (61, 88) |
96 (65, 175) |
0.271 |
Creatinine (mg/dl), Ме (LQ, UQ) |
1.1 (0.9, 1.2) |
1.0 (0.9, 1.1) |
0.177 |
Left ventricle hypertrophy on ECG (%), М (95% CI) |
7.5 (2.1, 12.9) |
22.5 (13.6, 31.3) |
0.004 |
Smoking cessation advice (%), М (95% CI) |
2.2 (0.9 – 5.2) |
1.1 (0.1 – 3.4) |
0.588 |
Dietary counseling (%), М (95% CI) |
53.8 (43.4 – 64.1) |
55.1 (44.5 – 65.6) |
0.861 |
Advice on physical activity (%), М (95% CI) |
5.4 (0.7 – 10.1) |
7.9 (2.2 – 13.6) |
0.500 |
Antihypertensive treatment (n), M±SD |
1.63 ± 0.12 |
1.98 ± 0.11 |
0.018 |
No antihypertensive drugs (%), М (95% CI) |
12.9 (6.0 – 19.8) |
9.0 (2.9 – 15.0) |
0.406 |
One antihypertensive drug (%), М (95% CI) |
40.9 (30.7 – 51.0) |
21.3 (12.7 – 30.0) |
0.005 |
Two antihypertensive drugs (%), М (95% CI) |
21.5 (13.0 – 30.0) |
39.3 (29.0 – 49.7) |
0.010 |
Three or more antihypertensive drugs (%), М (95% CI) |
24.7 (15.8 – 33.7) |
30.3 (20.6 – 40.1) |
0.399 |
ACE-inhibitors (%), М (95% CI) |
27.9 (18.7 – 37.2) |
39.3 (29.0 – 49.7) |
0.105 |
ARBs (%), М (95% CI) |
29.0 (19.6 – 38.4) |
30.3 (20.6 – 40.1) |
0.848 |
Beta-blockers (%), М (95% CI) |
46.2 (35.9 – 56.6) |
57.3 (46.8 – 67.8) |
0.136 |
Dihydrapiridine calcium antagonists (%), М (95% CI) |
20.4 (12.1 – 28.8) |
21.3 (12.7 – 30.1) |
0.879 |
Non-dihydrapiridine calcium antagonists (%), М (95% CI) |
4.3 (0.1 – 8.5) |
3.4 (0.1 – 7.2) |
0.745 |
Loop diuretics (%), М (95% CI) |
8.6 (2.8 – 14.4) |
9.0 (2.9 – 15.0) |
0.927 |
Thiazide diuretics (%), М (95% CI) |
3.2 (0.1 – 6.9) |
6.7 (1.4 – 12.1) |
0.275 |
Thiazide-like diuretics (%), М (95% CI) |
9.7 (3.6 – 15.8) |
21.4 (12.7 – 30.0) |
0.030 |
Potassium-sparing diuretics (%), М (95% CI) |
14.0 (6.8 – 21.2) |
9.0 (2.9 – 15.0) |
0.294 |
ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; CAD, coronary arteries disease; CI, confidence interval; ECG, electrocardiogram; LDL, low density lipoprotein; DBP, diastolic blood pressure; SBP, systolic blood pressure; SD, standard deviation.